Northwell Partnership Northwell Health partnership signals traction with a major US health system, creating a clear path for multi-site pilots and network-wide adoption of Neuromark. Leverage this to target similar large health systems and build payer-ready outcomes packages to accelerate reimbursement.

Manufacturing Scale Expansion of manufacturing in Ireland positions Neurent to meet European demand with improved supply security and service capabilities. Use this to pursue regional distributors and hospital groups with commitments based on reliable lead times and local support.

Funding Momentum Series C funding and high-profile board additions reflect strong financial backing and strategic governance to accelerate commercial expansion, evidence generation, and pipeline development. Use this to engage potential strategic investors or co-development partners and to fund sales enablement and KOL engagements.

Clinical Evidence Demand The Neuromark platform's unique neuromodulation approach aligns with rising demand for office-based, minimally invasive ENT treatments. Focus on generating clinical and economic outcomes data to support reimbursement, market access, and rapid clinician adoption for chronic rhinitis and related inflammatory diseases.

Strategic Differentiation Competitive landscape with large medical device players presents an opportunity to pursue distributor partnerships and potential collaboration or acquisition discussions. Emphasize ease of deployment, serviceability, and patient quality-of-life improvements to differentiate and win fast adoption in target markets.